Style | Citing Format |
---|---|
MLA | Lashay A, et al.. "Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes." Journal of Ophthalmic and Vision Research, vol. 15, no. 3, 2020, pp. 341-350. |
APA | Lashay A, Faghihi H, Mirshahi A, Khojasteh H, Khodabande A, Riaziesfahani H, Amoli FA, Pour EK, Delrish E (2020). Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes. Journal of Ophthalmic and Vision Research, 15(3), 341-350. |
Chicago | Lashay A, Faghihi H, Mirshahi A, Khojasteh H, Khodabande A, Riaziesfahani H, Amoli FA, Pour EK, Delrish E. "Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes." Journal of Ophthalmic and Vision Research 15, no. 3 (2020): 341-350. |
Harvard | Lashay A et al. (2020) 'Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes', Journal of Ophthalmic and Vision Research, 15(3), pp. 341-350. |
Vancouver | Lashay A, Faghihi H, Mirshahi A, Khojasteh H, Khodabande A, Riaziesfahani H, et al.. Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes. Journal of Ophthalmic and Vision Research. 2020;15(3):341-350. |
BibTex | @article{ author = {Lashay A and Faghihi H and Mirshahi A and Khojasteh H and Khodabande A and Riaziesfahani H and Amoli FA and Pour EK and Delrish E}, title = {Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes}, journal = {Journal of Ophthalmic and Vision Research}, volume = {15}, number = {3}, pages = {341-350}, year = {2020} } |
RIS | TY - JOUR AU - Lashay A AU - Faghihi H AU - Mirshahi A AU - Khojasteh H AU - Khodabande A AU - Riaziesfahani H AU - Amoli FA AU - Pour EK AU - Delrish E TI - Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes JO - Journal of Ophthalmic and Vision Research VL - 15 IS - 3 SP - 341 EP - 350 PY - 2020 ER - |